Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2026
Dietary intake and nutritional status in multiple sclerosis and associations with disease phenotype and management: A case-control study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ahmed Ali Mahmoud, Shaheen Emad Fawzy, Mohamed Mohie-Eldin Tharwat, Gaafar Abdallah Moustafa, Farghal Mohammed, Adam Bakar Ali
Аннотация
BACKGROUND: Nutrition and diet are increasingly recognised as potential modulators of immune function in multiple sclerosis (MS), but human studies remain conflicting and often focus on single nutrients. We aimed to investigate dietary intake in people with MS versus matched controls and to examine associations between dietary components, phenotype, disability, severity, and disease‑modifying therapy (DMT) status.
METHODS: In this cross-sectional case-control study, 270 adults with clinically confirmed MS and 255 originally age-matched controls completed a validated food-frequency questionnaire and provided clinical data. Exclusion of participants with invalid questionnaires partially disrupted the original matching, leaving residual imbalances in sex (67% female in MS vs 39% in controls) and BMI; analyses were therefore conducted as unmatched with adjustment for age, sex, and BMI. Comparisons between groups and associations between dietary components and clinical measures were analysed.
RESULTS: MS patients had lower body mass index and reported higher intake of vitamin D, β‑carotene, vitamins A, C, and E, folate, fruits, and vegetables, and lower intake of bread, pasta, rice, total fat, saturated fat, cholesterol and sodium compared with controls. Overall dietary composition differed significantly between MS patients and controls in multivariate analyses, including after adjustment for age and sex (PERMANOVA P = 0.046). In adjusted logistic regression, only vitamin D supplementation remained independently associated with MS status (P = 0.006). Within the MS cohort, dietary components including vitamin B6, polyunsaturated fat and vitamin A were not significantly associated with disability or progressive disease in adjusted analyses; the progressive-MS subgroup (n = 26) was small and these exploratory results should be interpreted with caution.
CONCLUSIONS: MS patients showed a different dietary pattern characterised by higher micronutrient and supplement intake, most likely reflecting post-diagnosis behavioural change rather than a pre-existing dietary difference. These are hypothesis-generating observations from an unmatched cross-sectional study with residual confounding; they do not support causal inference and should not inform dietary prescriptions without prospective confirmatory evidence.
METHODS: In this cross-sectional case-control study, 270 adults with clinically confirmed MS and 255 originally age-matched controls completed a validated food-frequency questionnaire and provided clinical data. Exclusion of participants with invalid questionnaires partially disrupted the original matching, leaving residual imbalances in sex (67% female in MS vs 39% in controls) and BMI; analyses were therefore conducted as unmatched with adjustment for age, sex, and BMI. Comparisons between groups and associations between dietary components and clinical measures were analysed.
RESULTS: MS patients had lower body mass index and reported higher intake of vitamin D, β‑carotene, vitamins A, C, and E, folate, fruits, and vegetables, and lower intake of bread, pasta, rice, total fat, saturated fat, cholesterol and sodium compared with controls. Overall dietary composition differed significantly between MS patients and controls in multivariate analyses, including after adjustment for age and sex (PERMANOVA P = 0.046). In adjusted logistic regression, only vitamin D supplementation remained independently associated with MS status (P = 0.006). Within the MS cohort, dietary components including vitamin B6, polyunsaturated fat and vitamin A were not significantly associated with disability or progressive disease in adjusted analyses; the progressive-MS subgroup (n = 26) was small and these exploratory results should be interpreted with caution.
CONCLUSIONS: MS patients showed a different dietary pattern characterised by higher micronutrient and supplement intake, most likely reflecting post-diagnosis behavioural change rather than a pre-existing dietary difference. These are hypothesis-generating observations from an unmatched cross-sectional study with residual confounding; they do not support causal inference and should not inform dietary prescriptions without prospective confirmatory evidence.